Zivo Bioscience Warrants Stock Probability Of Bankruptcy
| ZIVOWDelisted Stock | USD 0.55 0.07 14.58% |
Zivo |
Zivo Bioscience Warrants Company odds of financial turmoil Analysis
Zivo Bioscience's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Zivo Bioscience Probability Of Bankruptcy | Over 100% |
Most of Zivo Bioscience's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zivo Bioscience Warrants is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Zivo Bioscience probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Zivo Bioscience odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Zivo Bioscience Warrants financial health.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
CompetitionBased on the latest financial disclosure, Zivo Bioscience Warrants has a Probability Of Bankruptcy of 100%. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The probability of bankruptcy for all United States stocks is notably lower than that of the firm.
Zivo Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zivo Bioscience's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zivo Bioscience could also be used in its relative valuation, which is a method of valuing Zivo Bioscience by comparing valuation metrics of similar companies.Zivo Bioscience is currently under evaluation in probability of bankruptcy category among its peers.
Zivo Fundamentals
| Return On Equity | -39.56 | ||||
| Return On Asset | -1.65 | ||||
| Operating Margin | (133.25) % | ||||
| Number Of Shares Shorted | 5.63 K | ||||
| EBITDA | (8.73 M) | ||||
| Net Income | (8.75 M) | ||||
| Total Debt | 445.18 K | ||||
| Cash Flow From Operations | (7.1 M) | ||||
| Beta | 0.24 | ||||
| Market Capitalization | 35.33 M | ||||
| Total Asset | 2.12 M | ||||
| Retained Earnings | (115.8 M) | ||||
| Working Capital | (126.04 K) | ||||
| Z Score | -42.4 | ||||
| Net Asset | 2.12 M |
About Zivo Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zivo Bioscience Warrants's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zivo Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zivo Bioscience Warrants based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in Zivo Stock
If you are still planning to invest in Zivo Bioscience Warrants check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |